News

News about advances made possible through IPIRA's work, such as innovations commercialized, campus partnerships with industry, and companies born out of licensing UC Berkeley intellectual property rights.

All News

August 19, 2025

ChemFinity Technologies Raises $7M to Unlock Domestic Critical Mineral Recovery at Scale

Link

August 3, 2025

Male Contraceptive Pill ‘Found to be Safe’ in Early-Stage Trials

link

July 29, 2025

Addition Therapeutics: A Third-Way Approach to Genetic Medicine

link

July 15, 2025

How the Pow.bio Continuous Fermentation Platform is Reshaping the Future of Biomanufacturing

link

July 7, 2025

Nexilico Scales to 1.5 Million Microbiome Simulations and 40 Billion Metabolic Calculations

link

June 25, 2025

DOE Recognizes Synthetic Biology Pioneer Jay Keasling with 2025 OTC/NAI Innovator of the Year Award

link

June 23, 2025

Exelixis' blockbuster hopeful beats Bayer drug in pivotal cancer trial

link

June 17, 2025

Product Launch: Magan's HandShield™ Helps Protect Skin from Harmful Effects of LED Nail Gel Curing Lamps

link

June 11, 2025

Juvena Therapeutics and Lilly Enter Research Collaboration Focused on Muscle Health

link

June 5, 2025

Sanofi Pays $15M for Another STAT6 degrader from Fruitful Nurix Collab

link

June 3, 2025

UC Berkeley Awards $200K Venture Grant to HypO2Regen Therapeutics

link

May 29, 2025

Amyris Takes Full Ownership of Brazilian Industrial Fermentation Plant and Invests in Completion of Fourth Precision Fermentation Line

link

Seaweed Industry Experts Brought Together by the Energy Biosciences Institute's International Bioeconomy and Macroalgae Center (IBMC)

link

May 22, 2025

Bear market: UC Berkeley's plan to be the next big Silicon Valley VC

link

UC Berkeley School of Public Health Welcomes Fifth Health Innovation Accelerator Cohort

link

May 19, 2025

Juvena Therapeutics Announces Initiation of First-in-Human Clinical Trial of JUV-161

link

May 15, 2025

Infant Born with Deadly Disease Now Thriving Thanks to Customized CRISPR Treatment Six Months After Birth

link

Medical First: Infant Treated with Customized CRISPR Treatment in Collaboration Between 8 Academic and For-profit Organizations, Including IGI and Danaher

link

May 13, 2025

Federal appeals court sends CRISPR-Cas9 patent case back to patent office for reconsideration

link

Stylus Medicine Emerges from Stealth Mode with $85M in Financing

link